Market Expert, Ambareesh Baliga told CNBC-TV18, "There is enough reason to be into IT and pharma sectors. Pharma will continue to perform reasonably well. IT again the expectations have been tapered down to a certain extent because which the expectations are not too high for this results season. So, there may not be too much of disappointment as such. So, IT on correction is clearly a buy. I have been suggesting Infosys, Mindtree, HCL Tech and TCS for quite a while."
Tata Consultancy Services ended at Rs 2,524.70, up Rs 19.20, or 0.77 percent on the BSE.
The share touched its 52-week high Rs 2,834 and 52-week low Rs 2,160 on 07 October, 2014 and 19 May, 2014, respectively.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!